Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q3 2023 vs. Q2 2023
How the institutions holding Novo Nordisk A S changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 2 | +2 |
| Shares | 0 | 44.9K | +44.9K |
| Value | $0 | $4.09M | +$4.09M |
New holders (2)
Institutions that held Novo Nordisk A S at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 39,682 | $3.61M | 0.09% |
| Atlas Capital Advisors LLC | 5,218 | $476.4K | 0.08% |
Sold out (0)
Institutions that held Novo Nordisk A S at the end of Q2 2023 and filed for Q3 2023 without it.
None.